Yin X - Search Results

1

The first-generation drug-eluting stents and coronary endothelial dysfunction.

Pendyala LK, Yin X, Li J, Chen JP, Chronos N, Hou D. Pendyala LK, et al. Among authors: yin x. JACC Cardiovasc Interv. 2009 Dec;2(12):1169-77. doi: 10.1016/j.jcin.2009.10.004. JACC Cardiovasc Interv. 2009. PMID: 20129542 Free article. Review.

2

Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress.

Pendyala LK, Li J, Shinke T, Geva S, Yin X, Chen JP, King SB 3rd, Robinson KA, Chronos NA, Hou D. Pendyala LK, et al. Among authors: yin x. JACC Cardiovasc Interv. 2009 Mar;2(3):253-62. doi: 10.1016/j.jcin.2008.11.009. JACC Cardiovasc Interv. 2009. PMID: 19463433 Free article.

3

Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries.

Pendyala L, Yin X, Li J, Shinke T, Xu Y, Chen JP, King SB 3rd, Colley K, Goodchild T, Chronos N, Hou D. Pendyala L, et al. Among authors: yin x. EuroIntervention. 2010 May;6(1):126-33. EuroIntervention. 2010. PMID: 20542808

4

Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study.

Nakamura T, Winsor-Hines D, Yin X, Sushkova N, Chen JP, King SB 3rd, Chronos N, Eppihimer M, Huibregtse B, Dawkins KD, Hou D. Nakamura T, et al. Among authors: yin x. EuroIntervention. 2012 Aug;8(4):493-500. doi: 10.4244/EIJV8I4A77. EuroIntervention. 2012. PMID: 22917733 Free article.

5

Ghrelin and cardiovascular diseases.

Zhang G, Yin X, Qi Y, Pendyala L, Chen J, Hou D, Tang C. Zhang G, et al. Among authors: yin x. Curr Cardiol Rev. 2010 Feb;6(1):62-70. doi: 10.2174/157340310790231662. Curr Cardiol Rev. 2010. PMID: 21286280 Free PMC article.

6

Tissue Factor Pathway Inhibitor-Coated Stents Inhibit Restenosis in a Rabbit Carotid Artery Model.

Shi M, Yin F, Gu H, Zhu J, Yin X. Shi M, et al. Among authors: yin x, yin f. Cardiovasc Ther. 2015 Dec;33(6):353-9. doi: 10.1111/1755-5922.12152. Cardiovasc Ther. 2015. PMID: 26280363 Free article.

7

Changes in microRNA Expression Profiles in Diabetic Cardiomyopathy Rats Following H3 Relaxin Treatment.

Zhang X, Liu M, Yang K, Chi J, Chen W, Shi Z, Liu W, Ma X, Yin X. Zhang X, et al. Among authors: yin x. J Cardiovasc Pharmacol. 2022 Apr 1;79(4):530-538. doi: 10.1097/FJC.0000000000001211. J Cardiovasc Pharmacol. 2022. PMID: 34983906

8

H2 relaxin ameliorates angiotensin II-induced endothelial dysfunction through inhibition of excessive mitochondrial fission.

Gao L, Liu Y, Wang Y, Chen W, Yang K, Li J, Lv B, Zhang X, Chi J, Liu N, Yin X, Zhang X. Gao L, et al. Among authors: yin x. Biochem Biophys Res Commun. 2019 May 14;512(4):799-805. doi: 10.1016/j.bbrc.2019.03.112. Epub 2019 Mar 27. Biochem Biophys Res Commun. 2019. PMID: 30928096

9

Cortistatin attenuates vascular calcification in rats.

Liu Y, Zhou YB, Zhang GG, Cai Y, Duan XH, Teng X, Song JQ, Shi Y, Tang CS, Yin XH, Qi YF. Liu Y, et al. Among authors: yin xh. Regul Pept. 2010 Jan 8;159(1-3):35-43. doi: 10.1016/j.regpep.2009.09.005. Regul Pept. 2010. PMID: 19766150

10

Salt reduction and hypertension in China: a concise state-of-the-art review.

Liu Y, Li H, Hong S, Yin X. Liu Y, et al. Among authors: yin x. Cardiovasc Diagn Ther. 2015 Jun;5(3):191-6. doi: 10.3978/j.issn.2223-3652.2015.05.01. Cardiovasc Diagn Ther. 2015. PMID: 26090330 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,949 results

Search Page